Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1953 2
1973 1
1974 1
1975 1
1976 3
1977 3
1978 5
1979 4
1980 1
1981 3
1982 4
1983 4
1984 1
1986 3
1987 2
1988 2
1990 5
1991 2
1992 2
1994 6
1995 2
1997 6
1998 3
1999 3
2000 4
2001 7
2002 6
2003 2
2004 2
2005 2
2006 6
2007 2
2008 2
2009 5
2010 6
2011 9
2012 4
2013 9
2014 8
2015 5
2016 11
2017 14
2018 11
2019 9
2020 6
2021 14
2022 20
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

229 results

Results by year

Filters applied: . Clear all
Page 1
Wilderness Medicine.
Alexander W, Bright S, Burns P, Townes D. Alexander W, et al. Among authors: bright s. Med Clin North Am. 2016 Mar;100(2):345-56. doi: 10.1016/j.mcna.2015.09.003. Epub 2016 Jan 14. Med Clin North Am. 2016. PMID: 26900118 Review.
Efficacy and safety of single-agent belantamab mafodotin versus pomalidomide plus low-dose dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-3): a phase 3, open-label, randomised study.
Dimopoulos MA, Hungria VTM, Radinoff A, Delimpasi S, Mikala G, Masszi T, Li J, Capra M, Maiolino A, Pappa V, Chraniuk D, Osipov I, Leleu X, Low M, Matsumoto M, Sule N, Li M, McKeown A, He W, Bright S, Currie B, Perera S, Boyle J, Roy-Ghanta S, Opalinska J, Weisel K. Dimopoulos MA, et al. Among authors: bright s. Lancet Haematol. 2023 Oct;10(10):e801-e812. doi: 10.1016/S2352-3026(23)00243-0. Lancet Haematol. 2023. PMID: 37793771 Clinical Trial.
The future impacts of non-targeted effects.
Bright S, Kadhim M. Bright S, et al. Int J Radiat Biol. 2018 Aug;94(8):727-736. doi: 10.1080/09553002.2018.1454617. Epub 2018 Apr 11. Int J Radiat Biol. 2018. PMID: 29569509 Review.
To improve quality, leverage design.
Crowe B, Gaulton JS, Minor N, Asch DA, Eyet J, Rainosek E, Flint K, Joo J, Chambers C, Bright S, Yang JJ, Beyt G, Pierce R, Moses JM. Crowe B, et al. Among authors: bright s. BMJ Qual Saf. 2022 Jan;31(1):70-74. doi: 10.1136/bmjqs-2021-013605. Epub 2021 Sep 11. BMJ Qual Saf. 2022. PMID: 34510018 Free PMC article. No abstract available.
Signaling COVID-19 Vaccine Adverse Events.
Harpaz R, DuMouchel W, Van Manen R, Nip A, Bright S, Szarfman A, Tonning J, Lerch M. Harpaz R, et al. Among authors: bright s. Drug Saf. 2022 Jul;45(7):765-780. doi: 10.1007/s40264-022-01186-z. Epub 2022 Jun 23. Drug Saf. 2022. PMID: 35737293 Free PMC article.
Blood eosinophil-guided oral prednisolone for COPD exacerbations in primary care in the UK (STARR2): a non-inferiority, multicentre, double-blind, placebo-controlled, randomised controlled trial.
Ramakrishnan S, Jeffers H, Langford-Wiley B, Davies J, Thulborn SJ, Mahdi M, A'Court C, Binnian I, Bright S, Cartwright S, Glover V, Law A, Fox R, Jones A, Davies C, Copping D, Russell RE, Bafadhel M. Ramakrishnan S, et al. Among authors: bright s. Lancet Respir Med. 2024 Jan;12(1):67-77. doi: 10.1016/S2213-2600(23)00298-9. Epub 2023 Nov 2. Lancet Respir Med. 2024. PMID: 37924830 Free article. Clinical Trial.
Plant biotechnology.
Bright S. Bright S. Curr Opin Plant Biol. 1998 Apr;1(2):159-60. doi: 10.1016/s1369-5266(98)80018-6. Curr Opin Plant Biol. 1998. PMID: 10066581 Review. No abstract available.
229 results